Showing results (241-250 of 366) with videos related to
Sort By:
Pageof 37
Human Pathology|December 31, 2017
Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancerLaureen S Ojalvo, Elizabeth D Thompson, Tian-Li Wang, et al.Plos One|June 19, 2008
MicroRNA expression and identification of putative miRNA targets in ovarian cancerNeetu Dahiya, Cheryl A Sherman-Baust, Tian-Li Wang, et al.Cancer|December 6, 2011
Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinomaMohammed Tanjimur Rahman, Kentaro Nakayama, Munmun Rahman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphomaMartin Filipits, Ulrich Jaeger, Gudrun Pohl, et al.Cancer Research|April 23, 2009
Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomasKuan-Ting Kuo, Bin Guan, Yuanjian Feng, et al.The American Journal of Pathology|March 26, 2011
Somatic mutations of PPP2R1A in ovarian and uterine carcinomasIe-Ming Shih, Pradeep K Panuganti, Kuan-Tin Kuo, et al.Bioinformatics (Oxford, England)|February 8, 2011
DDN: a caBIG® analytical tool for differential network analysisBai Zhang, Ye Tian, Lu Jin, et al.Nature Communications|October 19, 2017
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinomaJennifer Ducie, Fanny Dao, Michael Considine, et al.The Journal of Pathology|August 16, 2021
Mutation and methylation profiles of ectopic and eutopic endometrial tissuesLihong Li, Maria Facadio Antero, Ming Zhang, et al.Breast Cancer Research and Treatment|October 24, 2003
Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapyMargaretha Rudas, Martin Filipits, Susanne Taucher, et al.Pageof 37